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FluorescenceAbstract A series of hydrazone derivatives 5a–5i were synthesized through multi-step reactions.
The 2-(2-oxo-1,2,3,4-tetrahydroquinoline-7-yloxy)acetohydrazide was prepared from 7-hydroxy-3,
4-dihydroquinolin-2(1H)-one as starting material. Then the condensation of 2-(2-oxo-1,2,3,4-tetra
hydroquinoline-7-yloxy)acetohydrazide with different o-hydroxyaldehyde derivatives 4a–4i yielded
into hydrazone derivatives 5a–5i. These hydrazone ligands were complexed with Zn (II) yielded
complexes 6a–6i. The molecular structures of the hydrazones 5a–5i and Zn (II) complexes 6a–6i
were characterized by FTIR, 1H and 13C NMR, LCMS, XRD, DSC-TGA, UV–Visible, Fluores-
cence and elemental analysis. The conductivity experiments showed that all the complexes are
non-electrolytes.The Preliminary results of antituberculosis study showed that most of the Zn
(II) complexes 6a–6i demonstrated very good antituberculosis activity while the ligands 4a–4i
showed moderate activity. Among the tested compounds 6c, 6e and 6h were found to be most active
with minimum inhibitory concentration (MIC) of 1.6 lg/mL against Mycobacteriumtuberculosis
(H37 RV strain) ATCC No.-27294 which is comparable to ‘‘first and second line’’ drugs used to
treat tuberculosis.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The frequency of infectious disease like tuberculosis in humans has
increased dramatically because of rising multidrug resistance. The ris-
ing clinical importance of drug-resistant bacterial pathogens has
impelled additional exigency to investigate more effective agents.
Therefore, searching for new antituberculosis agents with specific
activity, possibly acting through mechanism, which are different fromti-tuber-
2 M.C. Mandewale et al.those of familiar classes is of main interest. The modification in the
molecular structure of potential lead compounds is still an organized
and ruler approach to widen the vicinity of antimicrobial medicine
investigation.
The hydrazone ligands have been studied extensively for years, due
to the synthetic flexibilities, selectivity as well as sensitivity toward the
transition metal ions (Rao et al., 1997). Among the ligand systems,
quinoline hydrazone derivatives are highly important because, these
ligands developed due to their diverse chelating ability, structural flex-
ibility and pharmacological activities such as antimicrobial, anti-
inflammatory, analgesic, antifungal, antiviral, anticancer and anti-
tuberculosis (Uppal et al., 2011; Rollas and Kucukguzel, 2007; West
et al., 1993). The transition metal complexes of quinoline hydrazone
derivatives have gained increasing attention as antibacterials (Freixas
and Span, 1991; Babahan et al., 2013; Banerjee et al., 2009).
Recently it is reported that quinoline hydrazones and their Zn (II)
complexes showed significant activity anti-tuberculosis as well as fluo-
rescence properties (Eswaran et al., 2010; Thomas et al., 2011;
Vavrı´kova et al., 2011; Arafa et al., 2013; Hou et al., 2012). Based
on these facts, supported by literature and in continuation of our
research for new antituberculosis agents (Mandewale et al., 2015a,b,
2016), we have undertaken research studies on synthesis and biological
screening of some new quinoline hydrazone derivatives and their Zn
(II) complexes as shown in Fig. 1.
2. Experimental
2.1. Materials and methods
The chemicals used were of analytical grade and the solvents
were distilled before use according to the standard procedure.
The melting points of synthesized compounds were determined
in open capillary tubes and are uncorrected. UV–Visible spec-
tra were obtained on Shimadzu UV-1800 spectrophotometer
for scan range 200–800 nm. The path length of the measure-
ments was 1.0 cm. The fluorescence spectra were recorded on
a spectrofluorophotometer Shimadzu RF-5301pc havingN
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Figure 1 Previously reported quinoline hydr
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cular agents. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arab1 cm path length and 3 nm slit width for scan range 220.0–
900.0 nm. The concentration of 200 ppm of ligand and metal
complexes was prepared in DMF (N,N-dimethylformamide)
for study. Infrared spectra were measured with KBr pellet on
a FTIR-7600 Lambda Scientific Pty. Ltd., in the range 4000–
400 cm1. LCMS spectra were performed on BRUKER
ESQUIRE HCT spectrometer. 1H NMR and 13C NMR spec-
tra were recorded on Bruker AV II 300 spectrometer instru-
ment in DMSO-d6 using tetramethylsilane (TMS) as an
internal standard; chemical shifts are reported as d ppm units.
The DSC-TGA was carried out on Universal V4.5A TA
instrument. The spectral and elemental analyses were done at
the University of Mumbai and SAIF, IIT Mumbai, India.
2.2. Preparation of 2-(2-oxo-1,2,3,4-tetrahydroquinoline-7-
yloxy)acetohydrazide (3)
The 7-hydroxy-3,4-dihydroquinolin-2(1H)-one (1) (1 mmol)
was dissolved in DMF. To this clear solution 1.2 mmol of
K2CO3 was added followed by slow addition of 1 mmol of
methyl chloroacetate. Resultant solution was stirred at 80–
90 C for 3 h. After completion of the reaction it was poured
in ice cold water. Precipitated product was filtered and dried
in oven i.e. 2-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)acet
ate (2). The compound (2) was dissolved in methanol and
1.1 mmol hydrazine hydrate was added and stirred at room
temperature for 1 h. White shiny solid precipitated product
was filtered. Finally, the product (3) Fig. 2 was dried in oven.
2.3. Preparation of the hydrazones ligands
The compound (3) (0.01 mol) and appropriate aldehyde
derivatives (4a–4i) (0.01 mol) were taken in round bottom flax
containing 10 cm3 of ethanol. Reaction mixture was refluxed
for 30 min. Completion of reaction was checked with TLC.H
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Figure 2 Preparation of hydrazones 5a–5i and Zn (II) complexes 6a–6i.
Zinc complexes of hydrazone derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus 3Upon cooling the reaction mixture a solid product 5a–5i as
shown in Fig. 2 and Table 1 was precipitated out, which was
filtered, dried and purified by recrystallization from ethanol.
2.4. Preparation of Zn (II) complexes
A solution of ZnCl2 in methanol was added gradually to a stir-
red ethanolic solution of the hydrazone ligand (5a–5i) in the
molar ratio 1:2. The reaction mixture was further stirred for
2 h at 78 C. Then it was cooled in ice bath to ensure the com-
plete precipitation of the formed complexes (6a–6i) Fig. 2 and
Table 2. The precipitated solid complex was filtered and
washed with water. Finally, the complex was washed with
diethyl ether and dried in vacuum desiccators over anhydrous
CaCl2.
2.5. Spectral data
2.5.1. 2-[(2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy]
acetohydrazide (3)
Bright white solid (MeOH); mp 224–226 C; IR(KBr, t, cm1):
3322 (NH2), 3289 (NH), 3066, 3008 (ArCAH), 2913, 2856 (Ali-
phatic CAH), 1679 (C‚O), 1631 (C‚O), 1598; 1H NMR
(DMSO-d6, 300 MHz): d= 10.04 (s, 1H, ACOANHA), 9.33
(s, 1H, ANHANH2), 7.03–7.06 (m, 1H), 6.48–6.50 (m, 2H),
4.40 (s, 2H, AOACH2), 4.31 (s, 2H, ANH2), 2.75–2.80 (m,
2H, ACOACH2ACH2A), 2.38–2.43 (m, 2H, ACOACH2-
ACH2A); LCMS (98.793%) m/z: 236.00 [M+H] (100); Anal.
Calcd. for C11H13N3O3: C. 56.16; H, 5.57; N, 17.86. Found:
C, 54.98; H, 5.50; N, 17.93.
2.5.2. N0-[(E)-(2-hydroxyphenyl)methylidene]-2-[(2-oxo-
1,2,3,4-tetrahydroquinolin-7-yl)oxy] acetohydrazide (5a)
white spongy solid (EtOH); mp 285–287 C; IR(KBr, t, cm1):
3316 (OH), 3193 (NH), 3077 (ArCAH), 2975, 2944, 2915 (Ali-
phatic CAH), 1666 (C‚O), 1621 (ACH‚NA), 1598; 1H
NMR (DMSO-d6, 300 MHz): d= 12.03 (s, 1H, NH), 11.72Please cite this article in press as: Mandewale, M.C. et al., Zinc complexes of hydrazo
cular agents. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabj(s, 1H, NH), 10.08 (s, 1H, OH), 8.55 (s, 1H, ACH‚N),
7.12–7.71 (m, 2H), 6.85–7.52 (m, 3H), 6.47–6.56 (m, 2H),
4.62 (s, 2H, OACH2), 2.76–2.78 (m, 2H, ACOACH2ACH2A),
2.39–2.50 (m, 2H,ACOACH2ACH2A);
13C NMR (DMSO-d6,
75 MHz) d: 170.34 (C‚O), 170.30 (C‚O), 168.22 (CAOH),
156.59 (CAOACH2), 148.31 (AC‚NA), 141.51, 131.45,
129.25, 128.40, 126.37, 119.97, 119.23, 118.57, 107.62, 102.12,
101.67, 66.48 (OACH2), 33.66 (ACOACH2ACH2A), 23.97
(ACOACH2ACH2A); EIMS m/z: 340.84 [M+H] (32);
339.36 [M]+ (100); Anal. Calcd. for C18H17N3O4: C, 63.71;
H, 5.05; N 12.38. Found: C, 63.63; H, 5.12; N, 12.30.
2.5.3. N0-[(E)-(5-chloro-2-hydroxyphenyl)methylidene]-2-[(2-
oxo-1,2,3,4-tetrahydroquinolin-7-yl) oxy]acetohydrazide (5b)
white solid (EtOH); mp 284–286 C; IR(KBr, t, cm1): 3195
(OH), 3112 (NH), 3056 (ArCAH), 2979, 2892, 2844 (Aliphatic
CAH), 1675 (C‚O), 1627 (ACH‚NA), 1598; 1H NMR
(DMSO-d6, 300 MHz): d= 12.03 (s, 1H, NH), 11.72 (s, 1H,
NH), 9.97 (s, 1H, OH), 8.57 (s, 1H, ACH‚N), 8.42–8.48
(m, 1H), 7.76–7.91 (m, 1H), 7.04–7.83 (m, 4H), 4.60 (s, 2H,
OACH2), 2.78 (m, 2H, ACOACH2ACH2A), 2.50 (m, 2H,
ACOACH2ACH2A); LCMS (98.712%) m/z: 374.20 [M+H]
(100); Anal. Calcd. for C18H16ClN3O4: C, 57.84%; H, 4.31;
N, 11.24. Found: C, 57.78; H, 4.35; N, 11.17.
2.5.4. N0-[(E)-(5-bromo-2-hydroxyphenyl)methylidene]-2-[(2-
oxo-1,2,3,4-tetrahydroquinolin-7-yl) oxy]acetohydrazide (5c)
white solid (EtOH); mp 278–280 C; IR(KBr, t, cm1): 3191
(OH), 3106 (NH), 3052, 2977 (ArCAH), 2892, 2840 (Aliphatic
CAH), 1677 (C‚O), 1629 (ACH‚NA), 1598; 1H NMR
(DMSO-d6, 300 MHz) d: 11.56 (s, 2H, NH), 10.04 (s, 1H,
OH), 8.51 (s, 1H, ACH‚N), 7.74–7.81 (m, 2H), 7.36–7.43
(m, 2H), 7.03–7.09 (m, 2H), 4.61 (s, 2H, OACH2), 2.79 (m,
2H, ACOACH2ACH2A), 2.50 (m, 2H, ACOACH2ACH2A);
13C NMR (75 MHz, DMSO-d6) d: 170.31 (C‚O), 168.86
(C‚O), 164.35 (CAOH), 157.42 (CAOACH2), 145.67ne derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus as new anti-tuber-
c.2016.07.016
Table 1 Structures of hydrazones 5a–5i.
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4 M.C. Mandewale et al.(AC‚NA), 139.06, 133.40, 130.21, 128.24, 122.43, 121.18,
118.62, 116.52, 110.42, 107.62, 102.12, 101.77, 66.43 (OACH2),
30.67 (ACOACH2ACH2A), 23.97 (ACOACH2ACH2A);
LCMS (98.205%) m/z: 418.05 [M+H] (100); Anal. Calcd.
For C18H16BrN3O4: C, 51.69; H, 3.86; N, 10.05. Found: C,
51.60; H, 3.94; N, 10.12.
2.5.5. N0-[(E)-(1-hydroxynaphthalen-2-yl)methylidene]-2-[(2-
oxo-1,2,3,4-tetrahydroquinolin-7-yl) oxy]acetohydrazide (5d)
white solid (EtOH); mp 279–281 C; IR(KBr, t, cm1): 3212
(OH), 3092 (NH), 3048 (ArCAH), 2971, 2900 (Aliphatic
CAH), 1666 (C‚O), 1623 (ACH‚NA), 1598; 1H NMR
(300 MHz, DMSO-d6) d: 12.58 (s, 1H, NH), 11.88 (s, 1H,Please cite this article in press as: Mandewale, M.C. et al., Zinc complexes of hydrazo
cular agents. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabNH), 10.12 (s, 1H, OH), 8.90 (s, 1H, ACH‚N), 8.21–8.24
(m, 1H), 7.83–7.93 (m, 2H), 7.04–7.61 (m, 4H), 6.51–6.62 (m,
2H), 4.70 (s, 2H, OACH2), 2.79 (m, 2H, ACOACH2ACH2A),
2.50 (m, 2H, ACOACH2ACH2A); EIMS m/z: 390.23 [M+H]
(80); Anal. Calcd. For C22H19N3O4: C, 67.86; H, 4.92; N,
10.79. Found: C, 67.90; H, 5.02; N, 10.87.
2.5.6. N0-[(E)-(2-hydroxyquinolin-3-yl)methylidene]-2-[(2-
oxo-1,2,3,4-tetrahydroquinolin-7-yl) oxy]acetohydrazide (5e)
Yellow solid (EtOH); mp 297–299 C; IR(KBr, t, cm1): 3268
(OH), 3153 (NH), 3102 (NH), 3006 (ArCAH), 2964, 2900 (Ali-
phatic CAH), 2857, 1650 (C‚O), 1600 (ACH‚NA), 1521; 1H
NMR (300 MHz, DMSO-d6) d: 11.89 (s, 1H, NH), 11.59 (s,ne derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus as new anti-tuber-
jc.2016.07.016
Table 2 Preparation of Zn (II) complexes 6a–6i.
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Zinc complexes of hydrazone derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus 51H, NH), 11.08 (s, 1H, OH), 8.52 (s, 1H, ACH‚N), 8.25 (s,
1H), 7.62–7.71 (m, 2H), 7.25–7.33 (m, 2H), 7.03–7.09 (m,
3H), 4.62 (s, 2H, OACH2), 2.79 (m, 2H, ACOACH2ACH2A),Please cite this article in press as: Mandewale, M.C. et al., Zinc complexes of hydrazo
cular agents. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabj2.50 (m, 2H, ACOACH2ACH2A);
13C NMR (75 MHz,
DMSO-d6) d: 175.69 (C‚O), 170.26 (C‚O), 168.86 (CAOH),
164.33 (CAOACH2), 155.92, 145.89 (AC‚NA), 139.41,ne derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus as new anti-tuber-
c.2016.07.016
6 M.C. Mandewale et al.130.55, 128.23, 127.39, 124.99, 122.97, 121.90, 120.59, 118.18,
115.81, 107.60, 102.14, 66.48 (OACH2), 30.68 (ACOACH2-
ACH2A), 23.99 (ACOACH2ACH2A); LCMS (96.637%) m/
z: 391.05 [M+H] (100); Anal. Calcd. For C21H18N4O4: C,
64.61; H, 4.65; N, 14.35. Found: C, 64.56; H, 4.70; N, 14.43.
2.5.7. N0-[(E)-(6-fluoro-2-hydroxyquinolin-3-yl)methylidene]-
2-[(2-oxo-1,2,3,4-tetrahydroquin olin-7-yl)oxy]acetohydrazide
(5f)
Yellow solid (EtOH); mp above 300 C; IR(KBr, t, cm1):
3438 (OH), 3191 (NH), 3031, 2898 (ArCAH), 2854 (Aliphatic
CAH), 1662 (C‚O), 1610 (ACH‚NA), 1596; 1H NMR
(300 MHz, DMSO-d6) d: 12.12 (s, 1H, NH), 11.78 (s, 1H,
NH), 10.23 (s, 1H, OH), 8.55 (s, 1H, ACH‚N), 8.24–8.47
(m, 1H), 7.62–7.75 (m, 1H), 7.32–7.47 (m, 2H), 7.04–7.09 (m,
1H), 6.48–6.54 (m, 2H), 4.60 (s, 2H, OACH2), 2.79–2.81 (m,
2H, ACOACH2ACH2A), 2.39–2.44 (m, 2H, ACOACH2-
ACH2A);
13C NMR (75 MHz, DMSO-d6) d: 170.30 (C‚O),
169.08 (C‚O), 164.35 (CAOH), 160.58 (CAOACH2), 157.39
(CAF), 156.95 (AC‚NA), 139.08, 138.47, 135.65, 133.80,
128.30, 126.19, 119.70, 115.86, 113.37, 107.66, 102.05, 101.74,
66.40 (OACH2), 30.65 (ACOACH2ACH2A), 23.95
(ACOACH2ACH2A); LCMS (97.592%) m/z: 409.10 [M+H]
(100); Anal. Calcd. For C21H17FN4O4: C, 61.76; H, 4.20; N,
13.72. Found: C, 61.89; H, 4.13; N, 13.70.
2.5.8. N0-[(E)-(6-chloro-2-hydroxyquinolin-3-yl)methylidene]-
2-[(2-oxo-1,2,3,4-tetrahydroquin olin-7-yl)oxy]acetohydrazide
(5g)
Yellow solid (EtOH); mp above 300 C; IR(KBr, t, cm1):
3505 (OH), 3450 (NH), 3197 (NH), 3029, 2906 (ArCAH),
1643 (C‚O, ACH‚NA), 1596; 1H NMR (300 MHz,
DMSO-d6) d: 12.18 (s, 1H, NH), 11.80 (s, 1H, NH), 10.23 (s,
1H, OH), 8.55 (s, 1H, ACH‚N), 8.23–8.49 (m, 1H), 7.91–
8.07 (m, 2H), 7.05–7.59 (m, 2H), 6.48–6.54 (m, 2H), 4.48 (s,
2H, OACH2), 2.80 (m, 2H, ACOACH2ACH2A), 2.30 (m,
2H, ACOACH2ACH2A);
13C NMR (75 MHz, DMSO-d6) d:
170.29 (C‚O), 170.25 (C‚O), 169.03 (CAOH), 161.38
(CAOACH2), 160.88, 156.99, 142.80 (AC‚NA), 141.10,
138.84, 134.66, 133.61, 129.02, 125.05, 122.33, 118.96, 115.12,
107.69, 101.74, 66.45 (OACH2), 30.68 (ACOACH2ACH2A),
23.98 (ACOACH2ACH2A); LCMS (99.405%) m/z: 425.10
[M+H]; Anal. Calcd. For C21H17ClN4O4: C, 59.37; H, 4.03;
N, 13.19. Found: C, 59.44; H, 4.07; N, 13.11.
2.5.9. N0-[(E)-(6-bromo-2-hydroxyquinolin-3-yl)methylidene]-
2-[(2-oxo-1,2,3,4-tetrahydroquin olin-7-yl)oxy]acetohydrazide
(5h)
Yellow solid (EtOH); mp above 300 C; IR(KBr, t, cm1):
3513 (OH), 3436 (NH), 3193 (NH), 3027 (ArCAH), 2906 (Ali-
phatic CAH), 1643 (C‚O), 1612 (ACH‚NA), 1598; 1H
NMR (300 MHz, DMSO-d6) d: 12.17 (s, 1H, NH), 11.80 (s,
1H, NH), 10.22 (s, 1H, OH), 8.55 (s, 1H, ACH‚N), 8.04–
8.23 (m, 2H), 7.66–7.69 (m, 1H), 7.05–7.29 (m, 2H), 6.48–
6.54 (m, 2H), 4.60 (s, 2H, OACH2), 2.77–2.81 (m, 2H,
ACOACH2ACH2A), 2.39–2.44 (m, 2H, ACOACH2ACH2A);
EIMS m/z: 469.28 [M]+ (100), 471.78 [M+2] (90); Anal.Please cite this article in press as: Mandewale, M.C. et al., Zinc complexes of hydrazo
cular agents. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabCalcd. For C21H17BrN4O4: C, 53.75; H, 3.65; N, 11.94. Found:
C, 53.69; H, 3.61; N, 11.91.
2.5.10. (E)-N0-((2-hydroxybenzo[h]quinolin-3-yl)methylene)-
2-(2-oxo-1,2,3,4-tetrahydroquino lin-7-yloxy)acetohydrazide
(5i)
Faint yellow solid (EtOH); mp above 300 C; IR(KBr, t,
cm1): 3322 (OH), 3220 (NH), 3056 (ArCAH), 2908 (Aliphatic
CAH), 1667 (C‚O), 1629 (ACH‚NA), 1598; 1H NMR
(300 MHz, DMSO-d6) d: 12.06 (s, 1H, NH), 11.67 (s, 1H,
NH), 10.45 (s, 1H, OH), 8.86–9.07 (m, 2H), 8.50 (s, 1H,
ACH‚N), 7.80–8.14 (m, 4H), 7.04–7.12 (m, 2H), 6.42–6.58
(m, 2H), 4.67 (s, 2H, OACH2), 2.78–2.80 (m, 2H, ACOACH2-
ACH2A), 2.41–2.43 (m, 2H, ACOACH2ACH2A); EIMS m/z:
441.56 [M+H] (100); Anal. Calcd. For C25H20N4O4: C, 68.17;
H, 4.58; N, 12.72. Found: C, 68.12; H, 4.49; N 12.78.
2.5.11. Zn (II) complex of N0-[(E)-(5-bromo-2-
hydroxyphenyl)methylidene]-2-[(2-oxo-1,2,3,4-
tetrahydroquinolin-7-yl) oxy]acetohydrazide (6c)
Yellow solid (MeOH), IR(KBr, t, cm1): 3448 (lattice water),
1623 (imineAHC‚N), 1469 (CAO), 636 (MAN), 462 (MAO),
1H NMR (300 MHz, DMSO-d6) d: 12.03 (s, 2H, NH), 11.72 (s,
2H, NH), 8.57 (s, 2H, ACH‚N), 8.42–8.48 (m, 2H), 7.76–7.91
(m, 2H), 7.04–7.83 (m, 8H), 4.60 (s, 4H, OACH2), 2.78 (m, 4H,
ACOACH2ACH2A), 2.50 (m, 4H, ACOACH2ACH2A),
EIMS m/z: 900.00 [M+H] (100); Molar conductance Km:
10.2 X1 mol1 cm2, Anal. Calcd. For C36H30Br2N6O8Zn:
Zn, 6.99. Found: 7.04.3. Results and discussion
3.1. Chemistry
The hydrazone derivatives 5a–5i have been synthesized by con-
densation reaction of equimolar amounts of 2-(2-oxo-1,2,3,4-
tetrahydroquinoline-7-yloxy)acetohydrazide and 2-hydroxy-
aldehyde derivatives 4a–4i in warming ethanol at 70 C. The
required 2-(2-oxo-1,2,3,4-tetrahydroquinoline-7-yloxy)acetohy
drazide was prepared from 7-hydroxy-3,4-dihydroquinolin-2(
1H)-one as starting material. Finally, hydrazone derivatives
5a–5i were refluxed with ZnCl2 in ethanol with molar ratio
2:1 to offer Zn (II) complexes 6a–6i.
All the synthesized hydrazone ligands and their Zn (II)
complexes are stable at room temperature and are non-
hygroscopic in nature. The Zn (II) complexes are insoluble
in H2O but are soluble in DMF and DMSO. The spectral char-
acterizations (FT-IR, 1H and 13C NMR, MS, UV–Visible and
Fluorescence) of synthesized compounds confirm the sug-
gested structures of the hydrazones as well as their Zn (II)
complexes. The elemental analysis, physical properties and
spectral data of the ligand and complexes are summarized
below.
The FT-IR spectrum of hydrazone 5c, as a representative
example, showed strong absorption bands at 1677 and
1629 cm1 due to conjugated C‚N and C‚O functions,
respectively. The broad peak at 3191 cm1 is attributed to
hydroxyl group, which is present at 2nd position of quinoline
ring. The important IR peaks and their assignments are listedne derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus as new anti-tuber-
jc.2016.07.016
Table 3 1H NMR signals for hydrazones 5a–5i and their assignments.
Compound Amidea ANHA Amideb ANHA Phenolic AOH Imine ACH‚NA
1H NMR d FTIR (cm1) 1H NMR d FTIR (cm1) 1H NMR d FTIR (cm1) 1H NMR d FTIR (cm1)
5a 12.03 3193 11.72 3193 10.08 3316 8.55 1621
5b 12.03 3112 11.72 3112 9.97 3195 8.57 1627
5c 11.56 3106 11.56 3106 10.04 3191 8.51 1629
5d 12.58 3092 11.88 3092 10.12 3212 8.90 1623
5e 11.89 3153 11.59 3102 11.08 3268 8.52 1600
5f 12.12 3191 11.78 3191 10.23 3438 8.55 1610
5g 12.18 3450 11.80 3197 10.23 3505 8.55 1643
5h 12.17 3436 11.80 3193 10.22 3513 8.55 1612
5i 1206 3220 11.67 3220 10.45 3322 8.50 1629
a Cyclic.
b Non-cyclic.
Zinc complexes of hydrazone derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus 7in Table 3. Its 1H NMR spectrum revealed, in addition to
expected aromatic signals, three singlets at d 8.51, 10.04,
11.56 ppm are assignable to the azomethine proton
(ACH‚NA), hydroxyl proton (AOH) and amide proton
(ANHAC‚O), respectively. In addition, the 13C NMR spec-
trum of 5c displayed three characteristic peaks at d 145.67,
164.35, 168.86 and 170.31 ppm assignable to imine carbon,
carbon linked to hydroxyl group of quinoline, carbonyl carbon
of acyclic amide and carbonyl carbon of cyclic amide, respec-
tively. Moreover the LCMS spectrum of 5c revealed molecular
ion peak at m/z 418.05 (M+H) corresponding to the molecu-
lar formula [C21H18BrN3O3] with 98.205% purity. In a similar
manner, compounds 5a–5i were prepared and characterized.
FTIR spectra of all the zinc complexes show broad peak in
the region of 3330–3517 cm1 due to coordinated water mole-
cules. The FTIR spectral study is useful to explain the coordi-
nation mode of hydrazone with central metal ion Table 4. The
phenolic AOH band appears at 3139–3488 cm1 which disap-
pears in IR spectra of the metal complexes; however, new
broad peaks observed at 3330–3517 cm1 indicate coordinated
water molecules which confirms the coordination of hydra-
zones with Zn (II) through phenolic AOH. The IR spectra also
show new bands at 935–950 cm1 and 645–650 cm1, which
are attributed to q(H2O) and x(H2O) which indicate the pres-
ence of coordinated water molecules. The low frequency region
of the FTIR spectra showed the presence of two new mediums
to strong intensity bands at about 443–485 cm1 due to tMAO
vibrations. The IR spectra of all the metal complexes show
prominent band at about 501–620 cm1 due to tMANTable 4 Characterization of metal complexes 6a–6i and their assign
Entry FT-IR bands
Lattice water t(OH)
(cm1)
Imine t(C‚N)
(cm1)
t(CAO)
(cm1)
t(MAN)
(cm1)
6a 3387 1623 1444 590
6b 3407 1625 1473 649
6c 3448 1623 1469 636
6d 3340 1623 1461 646
6e 3376 1617 1444 640
6f 3361 1623 1417 617
6g 3392 1627 1427 630
6h 3390 1623 1411 642
6i 3380 1627 1438 638
Please cite this article in press as: Mandewale, M.C. et al., Zinc complexes of hydrazo
cular agents. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjstretching. It was observed that the azomethine proton in zinc
complex 6c appeared at 8.57 ppm after complexation with zinc
metal. This chemical shift was altered significantly downfield
due to deshielding effect exerted by zinc metal atom. Aromatic
protons of coumarin ring were observed at 7.04–8.42 ppm due
to the electron withdrawing mesomeric effect exerted by cen-
tral zinc metal atom.
The DSC-TGA was carried out to explain the thermal sta-
bility of the complexes. The thermal behavior of the metal
complex 6c was studied in temperature range of 25–1000 C.
The TG-DTA studies of complex 6c Fig. 3 show that the
decomposition occurs in three steps. The first stage involves
weight loss below 100 C due to the removal of the lattice cell
water in the complexes. Second step involves weight loss in the
temperature range 110–160 C is due to elimination of coordi-
nated water. A plateau was observed above 600 C corre-
sponding to the formation of ZnO. From the elemental
analysis of Zn (II) complexes 6a–6i, it is clear that observed
percentage of Zn content is in good agreement with the theo-
retical values as shown in Table 4.
The X-ray powder diffraction data provide vital structural
information of materials which do not yield single crystals of
good quality. Single crystals of the complexes under study
could not be prepared; thus, the powder diffraction data were
acquired for structural description (Bayoumi et al., 2013). The
X-ray diffractogram of the ligand and the complexes was mea-
sured in the range of 5–70 2h values, which are shown in
Fig. 4. The XRD pattern indicates that complex 6c has well
defined crystalline patterns, with various degrees of crys-ments.
Molar conductance Km
(X1 mol1 cm2)
% Zn observed
(calculated)t(MAO)
(cm1)
470 11.3 8.48 (8.40)
470 7.4 7.70 (7.72)
462 10.2 7.04 (6.99)
472 6.4 7.40 (7.45)
469 5.9 7.41 (7.43)
462 7.8 7.20 (7.14)
470 4.2 6.80 (6.89)
445 8.7 6.27 (6.30)
453 9.8 6.63 (6.67)
ne derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus as new anti-tuber-
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Figure 3 The DSC-TGA of Zn (II) complex 6c.
Figure 4 XRD spectra of Zn (II) complex 6c.
8 M.C. Mandewale et al.tallinity. The average crystallite size of the complex was calcu-
lated using Scherer’s formula. The Zn (II) complex 6c has an
average crystallite size of 76 nm (see Fig. 5).
From the mathematical relation Km= K/C the molar con-
ductance of the metal complexes (Km) can be calculated by dis-
solving in a proper solvent where,C is the molar concentration
(Mohamed et al., 2006). The solutions (103 M) of Zn (II) com-
plexes 6a–6i were prepared in DMF. The molar conductivities
were measured at 25 ± 2 C. The study shows negligible molar
conductance values for metal complexes 6a–6i (4.2–11.3 X1 -
mol1 cm2), indicating that the complexes are non-electrolytes.
The results are represented in Table 4. From the experimental
study, it is clear that practical observations are in goodPlease cite this article in press as: Mandewale, M.C. et al., Zinc complexes of hydrazo
cular agents. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabagreement with the theoretical values calculated for 1:2 ratio
of metal:ligand stoichiometry. From the above explanation
of the results of various spectroscopic studies, it may be con-
cluded that the proposed geometry for the Zn (II) complexes
with general formula ZnL2_s2H2O is octahedral for Zn (II)
complexes. The proposed structures are represented in Table 2.3.2. Biological evaluation (anti-tuberculosis activity)
The anti-microbial effects of the new hydrazones and their
Zinc complexes against Mycobacterium tuberculosis (H37 RV
strain) ATCC No.-27294, were evaluated at the Departmentne derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus as new anti-tuber-
jc.2016.07.016
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Figure 5 Percentage inhibition for test compounds against Mycobacterium tuberculosis.
Table 5 In vitro MTT assay results of hydrazones and their Zn (II) complexes.
Entry Compound % of inhibition at various concentrationsa
0.80 lg/mL 1.60 lg/mL 3.12 lg/mL 6.25 lg/mL 12.5 lg/mL 25 lg/mL 50 lg/mL 100 lg/mL
01 5a 0.0 0.0 4.5 22.6 45.3 66.2 79.1 93.5
02 5b 0.0 0.0 18.1 48.2 68.7 81.3 90.0 98.7
03 5c 0.0 0.0 20.4 50.3 77.6 84.5 91.6 99.2
04 5d 0.0 0.0 2.6 67.5 75.3 92.3 96.5 100
05 5e 0.0 0.0 6.8 25.7 78.9 81.6 89.4 97.4
06 5f 0.0 0.0 3.5 18.2 58.1 89.3 92.1 98.3
07 5g 0.0 0.0 2.5 21.3 45.3 88.7 93.2 98.8
08 5h 0.0 0.0 2.2 8.4 20.9 70.7 86.6 99.4
09 5i 0.0 0.0 0.0 2.4 23.5 86.4 97.4 98.8
10 6a 10.3 24.5 87.4 99.2 100 100 100 100
11 6b 9.5 31.2 90.2 98.7 100 100 100 100
12 6c 12.5 88.7 98.2 100 100 100 100 100
13 6d 6.1 22.6 84.1 95.4 99.2 100 100 100
14 6e 9.1 78.4 97.2 100 100 100 100 100
15 6f 6.4 16.3 69.5 91.2 97.4 99.2 100 100
16 6g 7.3 15.8 31.3 82.7 90.5 95.4 100 100
17 6h 15.4 91.2 97.4 100 100 100 100 100
18 6i 5.6 17.1 28.9 81.0 89.6 98.1 100 100
a The data presented are the average of three separate experiments. Ciprofloxacin (MIC 3.12 lg/mL), Pyrazinamide (MIC 3.12 lg/mL) and
Streptomycin (MIC 6.25 lg/mL) were used as reference compounds against Mycobacterium tuberculosis with 100% inhibition.
Zinc complexes of hydrazone derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus 9of Microbiology, Maratha Mandal’s NGH Institute of Dental
Sciences and Research Centre, Belgaum-590010, India. The
method applied is similar to that reported by Maria and Lour-
enco (Lourenco et al., 2007). Ciprofloxacin (MIC 3.12 lg/mL),
Pyrazinamide (MIC 3.12 lg/mL) and Streptomycin (MIC
6.25 lg/mL) were used as references to evaluate the potency
of the synthesized compounds.
All the studied samples are showing different potency due
to the effective barrier of an outer cell wall membrane of M.
tuberculosis for entry of external substances like test com-
pounds under this study. However, hydrazone ligands 5a–5i
showed less activity than their Zn (II) complexes 6a–6i. As
shown in Table 5, complex 6c, 6e and 6h has unpredictable
high anti-tuberculosis activity against M. tuberculosis as their
MIC value is 1.6 lg/mL. This could be as a result of the metal
chelates, which bear polar and nonpolar properties together;
this makes them suitable for permeation to the bacterial cell.
This finding indicates that complex formation enhanced the
amphiphilic properties and solubility and hence, the penetra-Please cite this article in press as: Mandewale, M.C. et al., Zinc complexes of hydrazo
cular agents. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjtion of complex 6c, 6e and 6h into the cell wall of theM. tuber-
culosis, which translated into better activity. According to the
Molecular Theory of Coordination metal orbital overlap with
ligand orbitals this decreases the positive charge on the metal
ion by accepting the electrons from donor groups of the hydra-
zone ligand (Kralova et al., 2004; Parekh et al., 2005). Thus,
the donation of the electrons from ligand to metal also favors
the increased delocalization of the p-electrons through entire
coordinating rings. This results in increased lipophilicity of
the metal complexes. This finding indicates that complex for-
mation enhanced the physical properties such as solubility
and amphiphilicity and hence, the penetration of complex 6c,
6e and 6h into the cell wall of theM. tuberculosis, which trans-
lated into better activity (Vaghasia et al., 2004).
In addition, these metal complexes disturb the respiration
process of the cell and thereby restrict the synthesis of proteins.
If the synthesis of proteins is blocked then formation bacterial
cell wall is not possible which ultimately results in cell death
and therefore restricts further growth and infection of thene derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus as new anti-tuber-
c.2016.07.016
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Figure 6 Electronic spectra of hydrazones.
Table 6 The absorption and emission wavelength (nm).
Hydrazone Absorption kmax (intensity) Emission kmax (intensity) Complex Absorption kmax (intensity) Emission kmax (intensity)
5a 280 (2.83) 422 (24.76) 6a 296 (0.86) 480 (427.26)
5b 281 (2.65) 380 (55.76) 6b 296 (1.01) 485 (489.54)
5c 282 (2.20) 429 (26.44) 6c 395 (1.15) 464 (237.45)
5d 322 (1.70) 446 (82.08) 6d 295 (0.77) 467 (241.00)
5e 320 (2.82) 442 (135.51) 6e 404 (0.87) 488 (332.04)
5f 307 (1.44) 451 (254.51) 6f 335 (0.73) 466 (146.01)
5g 384 (1.62) 449 (333.86) 6g 386 (1.28) 475 (111.13)
5h 379 (1.85) 443 (395.51) 6h 393 (0.75) 451 (471.86)
5i 319 (0.92) 411 (322.87) 6i 286 (1.18) 412 (352.36)
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Figure 7 Electronic spectra of complexes 6a–6i.
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Figure 9 Fluorescence spectra of complexes 6a–6i.
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Figure 8 Fluorescence spectra of hydrazones 5a–5i.
10 M.C. Mandewale et al.bacteria (Raman, 2005). According to one more probable
mechanism, these complexes might be interacting with the
DNA gyrase enzyme, which is necessary for DNA multiplica-
tion step. The DNA gyrase is inhibited by metal complexes,
which alters the multiplication of bacterial cells, eventually
resulting in death of the bacteria (Galm et al., 2004; Alvarez
et al., 1997). The observed results of the test compounds indi-
cate the future potential for the development of metal coordina-
tion complexes to solve the limitations due to currently existing
anti-tuberculosis agents to treat multiple drug resistant
Tuberculosis.Please cite this article in press as: Mandewale, M.C. et al., Zinc complexes of hydrazo
cular agents. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arab3.3. Fluorescence study
The UV–Visible and fluorescence study was done at room tem-
perature. The spectra of the ligands 5a–5i exhibit bands
around 280–384 nm as represented in Fig. 6 and Table. 6. This
broad, intense band in the ligands can be assigned to intra
ligand n? p* transition associated with the azomethine
linkage. Table 6 and Fig. 7 show this band experiences red shift
in all the complexes 6a–6i. The bands at around 286–404 nm
are attributed to the L?M charge transfer transitions.ne derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus as new anti-tuber-
jc.2016.07.016
Zinc complexes of hydrazone derivatives bearing 3,4-dihydroquinolin-2(1H)-one nucleus 11The emission spectra of compounds 5a–5i Fig. 8 showed the
emission band in the range of 380–457 nm and complexes 6a–
6i Fig. 9 and Table 6 showed emission band in the range of
412–488 nm. Complex formation of hydrazones induces the
marked hyperchromic and bathochromic shifts. The Zn (II)
complexes demonstrated intense fluorescent properties as com-
pared to their parent ligands. The incorporation of Zn (II)
effectively increases the conformational rigidity of the hydra-
zones and increases the fluorescence intensities of the com-
plexes 6a–6i, which shows that it is a good material in
photochemical applications of these complexes.
4. Conclusion
In conclusion, new hydrazone derivatives bearing 3,4-
dihydroquinoline nucleus have been synthesized in a short reaction
time with good yield. This synthetic strategy allows for the assimilation
of 3,4-dihydroquinoline and quinoline in a single scaffold through an
easy way. The Antituberculosis analysis was performed using blue Ala-
mar method to identify the more effective compound. Most of the syn-
thesized compounds show moderate to good antituberculosis
properties. Of the compounds studied 6c, 6e and 6h have proven as
the efficient antitubercular member. Subsequently UV and Fluores-
cence spectral study of the synthesized compounds was performed. It
indicates that Zn (II) complexes are more emissive than their parent
ligands. This study would pave the way for future development of
more effective dihydroquinoline hydrazone analogs for applications
in biological and material science.
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